Dyne Therapeutics

Our #Dynamos wore green in support of International #MyotonicDystrophy Awareness Day. Today and every day, we are inspired by our community, which fuels our efforts to deliver a potentially transformative therapeutic for individuals living with #DM1.

Sarah shares her powerful story of living with #DM1, how the disease impacts her daily life, and why she believes a transformative therapy is urgently needed. In honor of International Myotonic Dystrophy Awareness Day on Sunday, watch her story and hear other perspectives from our #DM1 community members: https://bit.ly/4bTnxe0 #myotonicdystrophy

Dyne partnered with Duchenne muscular dystrophy (#DMD) and myotonic dystrophy type 1 (#DM1) advocates across the globe to inform the design of our clinical trials and to reduce the burdens and inconveniences to trial participants and their families. These findings were published in the journal Research Involvement and Engagement. In honor of #WDAD24 and International #MyotonicDystrophy Awareness Day this month, we're excited to share an insightful conversation from Pat Furlong, founding president and CEO of Parent Project Muscular Dystrophy (PPMD) and Ashish Dugar, PhD, MBA, our Chief Medical Affairs Officer, about this collaboration. Watch the full video: https://bit.ly/3N3brVP and read the paper: https://bit.ly/4dMU8mW #clinicialtrials #patientcenteredresearch

This Sunday is International #MyotonicDystrophyAwareness Day. Myotonic dystrophy type 1 (DM1) is a rare, progressive muscle disease distinguished by myotonia. Visit the Myotonic Dystrophy Foundation to learn more about #DM1 and how to get involved: https://bit.ly/3XhaQEE

We’re proud to sponsor the All Wheels Up Global Forum for Wheelchair Accessible Travel, which brings together people from around the world to address the critical need to secure wheelchair spots on commercial aircraft. Learn more: https://bit.ly/4ek3cAh #AllWheelsUp

On #WorldDuchenneAwarenessDay, we proudly wear red in support of raising awareness of #DMD. Today & every day, we stand with the Duchenne community, listening to their stories & learning from their experiences. Join us in amplifying their voices: https://bit.ly/3Szd3ug #WDAD2024

In honor of #WorldDuchenneAwarenessDay, Dyne hosted Marissa Penrod, CEO of Team Joseph, to discuss the important work the organization is doing to elevate voices we seldom hear—caregivers of people living with Duchenne—and the challenges they encounter. Thank you, Marissa, for such an insightful discussion, and for sharing an overview of “The Duchenne Community Voices Initiative - Engulfed in Caregiving," report which highlighted themes characterizing the caregiver experience in Duchenne. #WDAD2024

Today, we’ll be presenting at the 22nd Annual Morgan Stanley Global Healthcare Conference at 4:05 p.m. ET. Register here: https://bit.ly/3Zd8sBh #investors #biotechnology

This Saturday is #WorldDuchenneAwarenessDay! We’re looking forward to joining the Jett Foundation for their #WDAD24 events to raise awareness of #DMD and honor the community. Register to learn about their luncheon and virtual panel, and how you can get involved in the activities: https://bit.ly/4e9GwCB #JettFoundationWDAD

The 2024 Muscle to Keep Life Moving™ fundraising event was spectacular! Thank you to the FSHD Society for partnering with us and to everyone who participated to help raise $145,000 to provide care and support for those with serious muscle diseases. Your generous contributions also helped provide a wheelchair-accessible van to a family in need. #biotechnology #raredisease